Purchase Order VA26312P0403

This $7,086 firm-fixed price purchase order was awarded by the Southeast Area of the U.S. government's civilian agency to Azenta US Inc., doing business as Brooks Life Sciences Inc. The contract is for DNA sequencing of PCR products using Sanger sequencing. The contractor must be able to sequence samples in 96-well plate format as well as single tubes, provide a 24-hour turnaround time, and offer pricing of approximately $6 per base for tubes and $4 per base for plates. The contract does not...

<p>The National Human Genome Research Institute awarded a purchase order to Pacific Biosciences of California, Inc. for $10,208.00 on April 30, 2021, for SEQUEL II SEQUENCING KIT 2.0 BDLE (5-PK).</p> <p>Performance is located in North Bethesda, Maryland. The order carried a firm fixed price and was completed on April 30, 2021. No set-aside applied.</p>

The National Institutes of Health Clinical Center awarded a $279,999.93 firm-fixed price purchase order to Illumina, Inc. of San Diego, California. The contract calls for Illumina to provide two NextSeq 1000 Sequencing Systems to replace older equipment. The solicitation sought sequencing systems that could automatically generate DNA clusters and perform sequencing, primary, and secondary analysis compatible with existing assays, reagents, consumables, software, and workflows. As the only vendor...

<p>The National Human Genome Research Institute issued a purchase order to Pacific Biosciences of California, Inc. on October 8, 2020, with a ceiling value of $23,531.00 to perform high-throughput, large-scale DNA sequencing and sequence analysis. Work is performed in Menlo Park, California. The order carries firm fixed-price pricing and has an ultimate completion date of December 8, 2020.</p>

The National Cancer Institute issued a purchase order to Life Technologies Corporation on September 15, 2020, for BDT kits used in Sanger DNA sequencing and genotyping, with a ceiling value of $17,416.80 and a firm fixed price. Work is performed at the vendor's facility in Grand Island, New York. The order is for consumable supplies that LTG scientific staff use to verify cloned construct sequences and genotype human DNA samples. The order is scheduled for completion by September 30, 2020.

This is a $99,900 firm-fixed price purchase order awarded by the Food and Drug Administration (FDA) to Seqmatic, LLC, a minority-owned, Asian-Pacific American-owned small business based in Fremont, California. The contract is for the purchase of next-generation sequencing (NGS) RNA reagents tests, with a period of performance through September 7, 2026. The contract was awarded under a full and open solicitation, with no set-aside designation. Seqmatic will perform bulk RNA transcriptomics...

This $438,600 firm fixed price purchase order was awarded by the Department of Health and Human Services Food and Drug Administration to Pacific Biosciences of California, Inc. to deliver a SEQUEL IIE SYSTEM long-read DNA/RNA sequencing machine. The solicitation sought quotes for a turnkey sequencing solution to detect pathogen variants, access previously inaccessible genomic regions, and advance genetic research at the FDA's Center for Biologics Evaluation and Research Division of Cell and Gene...

The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $240,622 firm fixed price purchase order to Baylor College of Medicine. The contract calls for whole genome sequencing of 200 samples to support NIAID's research efforts. Specifically, the contractor will perform clinical whole genome sequencing, sample processing, and data analysis on samples provided by NIAID. The sequencing must meet CLIA and CAP...

The National Institute of Environmental Health Sciences (NIEHS) awarded a $222,000 firm fixed-price purchase order to Complete Genomics LLC for the supply of a DNBseq T1+ sequencer. The contract, awarded on September 19, 2025, with an ultimate completion date of March 19, 2026, supports the NIEHS Epigenomics core facility to increase sequencing capacity and enhance genomic research capabilities. This sole-source acquisition was conducted without a set-aside designation and involves delivery to...

This $340,025 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Illumina, Inc. to deliver an Illumina NextSeq 2000 Sequencer or equivalent high-throughput next-generation sequencing system. The solicitation sought quotes for this sequencing equipment to increase NIAID's capacity for sequencing samples related to...